AirLife Completes Acquisition of Avanos Medical’s Respiratory Health Business

Rhea-AI Summary

AirLife completes acquisition of Avanos Medical's respiratory health business, adding three complementary brands and two manufacturing facilities to its platform. The transaction advances AirLife's strategy to enhance its portfolio and serve more customers as a one-stop source for consumable breathing solutions.

Positive

• AirLife strengthens its position in the market with the acquisition, unlocking new opportunities for growth and innovation.
• The addition of Avanos Medical's respiratory health business expands AirLife's portfolio and increases its customer base.

Negative

• None.

GRAND RAPIDS, Mich.--(BUSINESS WIRE)-- AirLife, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care formerly known as SunMed, today announced the completion of its acquisition of Avanos Medical, Inc.’s (NYSE: AVNS) (“Avanos”) respiratory health business, including the BALLARD*, MICROCUFF* and endOclear® product lines.

The acquisition adds three complementary brands, the R&D expertise behind them and two manufacturing facilities into AirLife’s growing platform. The transaction advances AirLife’s strategy to enhance its leading portfolio of the most trusted products in anesthesia and respiratory care and serve even more customers as a one-stop source for the highest-quality consumable breathing solutions that support the best patient outcomes.

“We’re thrilled to complete this exciting milestone in AirLife’s evolution as we strengthen our leadership as a premier, completely dedicated consumable breathing products company,” said Hank Struik, AirLife CEO. “We are especially pleased to welcome the exceptional team that has driven the success of these market leading brands to our company. As some of the most trusted closed suction and endotracheal consumables used to treat patients in critical care, this addition to AirLife unlocks new opportunities to accelerate our growth, serve more healthcare practitioners and drive innovation across our comprehensive portfolio of leading brands.”

Goodwin Procter LLP is acting as legal counsel to AirLife.

About AirLife

AirLife, formerly known as SunMed and headquartered in Grand Rapids, Michigan with manufacturing and distribution sites in the United States, Mexico, China and Europe, is a leading medical device manufacturer, offering one of the most comprehensive portfolios of consumable anesthesia and respiratory care products. AirLife’s product portfolio spans the continuum of care from first responders to hospitals and home care, with safety, patient comfort and clinical performance in mind. AirLife’s comprehensive portfolio of trusted anesthesia products and respiratory care include premier brands such as Salter Labs®, Ethox Medical™, Ventlab™, Westmed™, AirLife™ and Vital Signs™. Currently, AirLife has over 1 million square feet of manufacturing space, providing comprehensive expertise in all plastics materials and conversion—supported by a world-class Quality Management System. Frazier Healthcare Partners, a leading healthcare investment firm, acquired a majority ownership stake in AirLife in 2021.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231002578607/en/

Media

FGS Global

AirLife@fgsglobal.com

Source: AirLife